Due to the low specificity of PSA, only 25–40 % of patients with a PSA of 2–10 ng/ml are diagnosed with prostate cancer on biopsy, resulting in a substantial number of unnecessary biopsies [5, 6]. Here, KLK3 is linked to prostate cancer.